FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

LALPATHLAB Share Price Discussion

Dr. Lal Path Labs Ltd.
NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Sector: Pharmaceuticals and health care

LALPATHLAB - chart - 1327409
View - Dr Lalpathlabs Ltd LTP 1974.80/-Rs Action - Buy
Target Price 2300/-Rs
Stop Loss - 1843/-Rs Below Closing
Cup Pattern Breakout at 2029/-Rs
MACD Signal - 5.69 Turning Positive
Note - Volumes Have to pick up As trading Below 10D AVG Volumes 137.957K
Disclaimers: - The contents produced here are purely for Educational Purposes. They Should Not Be Constructed as Buy/Sell Recommendations
Financial Interest - Yes
2
Reply (1)
NSE:LALPATHLAB price when posted: 1,989.5
1 Replies

Expects Diagnostic stocks will be positive after Thyrocare Technologies announced strong earning guidance. Stock gained nearly 30% in the last two trading sessions after the announcment. Company says that it has conducted more than 4 lakh Covid-19 RT-PCR tests and more than 3.2 lakh Covid-19 antibody tests as on September 30. Have enhanced capacity to do RT-PCR tests up to 400 per hour. Revenue for the quarter up 37% as compared to last year and up 171% as compared to the previous quarter. Expects positive for other Diagnostic stocks like Dr Lal Pathlab, Metropolis and Apollo Hospital
Recent posts in LALPATHLAB

LALPATHLAB - chart - 1527387
#LALPATHLAB MEDIUM TERM ABC BULLISH BO DONE TGT 2725/3359 SL 2050 ( WEEKLY CLBS )
Like
Reply
Post in Positional Trades (Swing,Momentum,Trending,Invest) channel on FrontPage
No access
FrontPage
Like
Reply
A
Reputation: -33 • Oct 12 6:06 AM

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,132
Price@Trade
₹2,132
Target Price
₹2,140
Stop Price
₹2,125  ₹2,131.4
Valid Till
Oct 12, 2020 3:20 AM
Margin
₹213,200 approx for 100 Qty
Status
Stoploss Hit
Exit Price
2131.4
Net P&L
-₹60 (-0.03%)
Like
Reply (4)

Dr Lal Pathlabs has clarified that the data breach of patients was a result of misconfiguration in one of the company's minor web applications where temporary records were stored for operational purposes. It involved less than 0.5% of the records and the issue has been resolved s...
Read more...
Like
Reply
N
Reputation: 7,260 • Oct 9 2:23 AM
Dr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: Report
The data included patients’ booking details such as their name, address, phone number, email id, payment details, digital signature, and also the type of medical tests they had taken.
Moneycontrol
Like
Reply
K
Reputation: 1,864 • Oct 8 8:33 AM

Type
Buy
Instrument
LALPATHLAB
Entry Price
₹2,157.9  ₹2,157.1
Price@Trade
₹2,158.95
Target Price
₹5,000
Stop Price
₹400
Valid Till
Oct 8, 2021 3:20 AM
Margin
₹899,510.7 approx for 417 Qty
Status
Exited
Exit Price
₹2,197.4
Net P&L
+₹16,805.1 (+1.87%)
Like
Reply (3)